Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcription, Genetic | 3 | 2015 | 1761 | 0.620 |
Why?
|
| Estrogen Receptor alpha | 4 | 2020 | 475 | 0.600 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2015 | 22 | 0.490 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2015 | 52 | 0.490 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2013 | 128 | 0.390 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2013 | 76 | 0.380 |
Why?
|
| Receptors, Progesterone | 1 | 2015 | 898 | 0.360 |
Why?
|
| Receptors, Androgen | 4 | 2020 | 433 | 0.330 |
Why?
|
| HeLa Cells | 5 | 2020 | 838 | 0.270 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2025 | 64 | 0.240 |
Why?
|
| NAV1.6 Voltage-Gated Sodium Channel | 1 | 2025 | 24 | 0.230 |
Why?
|
| Adipose Tissue, White | 1 | 2025 | 93 | 0.220 |
Why?
|
| Benzhydryl Compounds | 2 | 2016 | 68 | 0.220 |
Why?
|
| Mediator Complex | 2 | 2015 | 57 | 0.220 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 131 | 0.200 |
Why?
|
| High-Throughput Screening Assays | 4 | 2020 | 110 | 0.200 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 358 | 0.200 |
Why?
|
| RNA Splicing Factors | 1 | 2021 | 55 | 0.180 |
Why?
|
| Transcriptional Activation | 3 | 2024 | 504 | 0.170 |
Why?
|
| Adenosine | 1 | 2021 | 140 | 0.170 |
Why?
|
| Software | 1 | 2024 | 735 | 0.160 |
Why?
|
| Fibroblasts | 1 | 2024 | 928 | 0.160 |
Why?
|
| Endocrine Disruptors | 1 | 2020 | 54 | 0.160 |
Why?
|
| Myocardium | 1 | 2024 | 1046 | 0.150 |
Why?
|
| Oxidative Stress | 1 | 2024 | 877 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2024 | 616 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2025 | 951 | 0.140 |
Why?
|
| Databases, Genetic | 1 | 2020 | 507 | 0.140 |
Why?
|
| RNA | 1 | 2021 | 607 | 0.140 |
Why?
|
| Microscopy | 3 | 2016 | 124 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2025 | 880 | 0.140 |
Why?
|
| Cell Line, Tumor | 5 | 2020 | 3798 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 709 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2020 | 806 | 0.130 |
Why?
|
| src-Family Kinases | 1 | 2016 | 97 | 0.130 |
Why?
|
| Gonanes | 1 | 2015 | 17 | 0.130 |
Why?
|
| Promegestone | 1 | 2015 | 32 | 0.120 |
Why?
|
| Chromones | 1 | 2015 | 26 | 0.120 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2016 | 40 | 0.120 |
Why?
|
| Mifepristone | 1 | 2015 | 139 | 0.120 |
Why?
|
| Morpholines | 1 | 2015 | 64 | 0.120 |
Why?
|
| Purines | 1 | 2015 | 119 | 0.120 |
Why?
|
| Polymers | 1 | 2016 | 118 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 1167 | 0.120 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2016 | 98 | 0.110 |
Why?
|
| Genes, Reporter | 2 | 2013 | 398 | 0.110 |
Why?
|
| Androgens | 1 | 2016 | 300 | 0.110 |
Why?
|
| Transcription Factors | 2 | 2021 | 2738 | 0.110 |
Why?
|
| Phenols | 1 | 2014 | 57 | 0.110 |
Why?
|
| Estrogen Receptor beta | 1 | 2014 | 87 | 0.110 |
Why?
|
| Obesity | 1 | 2025 | 2446 | 0.100 |
Why?
|
| Prolactin | 1 | 2013 | 116 | 0.100 |
Why?
|
| Fibrosis | 2 | 2025 | 463 | 0.100 |
Why?
|
| Biocatalysis | 1 | 2012 | 37 | 0.100 |
Why?
|
| Protein Structure, Secondary | 1 | 2013 | 256 | 0.100 |
Why?
|
| Chromatin | 2 | 2013 | 617 | 0.100 |
Why?
|
| Hydrolases | 1 | 2012 | 61 | 0.100 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 1440 | 0.090 |
Why?
|
| Genomics | 1 | 2020 | 1681 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2016 | 2563 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2024 | 4934 | 0.090 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2013 | 211 | 0.090 |
Why?
|
| Citrulline | 1 | 2012 | 114 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 825 | 0.090 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2013 | 351 | 0.090 |
Why?
|
| Models, Biological | 1 | 2015 | 1539 | 0.080 |
Why?
|
| Arginine | 1 | 2012 | 351 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2016 | 1631 | 0.080 |
Why?
|
| Histones | 1 | 2012 | 573 | 0.070 |
Why?
|
| Humans | 13 | 2025 | 134156 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 1626 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 3043 | 0.060 |
Why?
|
| Mice | 4 | 2025 | 19055 | 0.060 |
Why?
|
| Neoplasms | 1 | 2020 | 3038 | 0.060 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2025 | 52 | 0.060 |
Why?
|
| MCF-7 Cells | 2 | 2016 | 233 | 0.060 |
Why?
|
| Patch-Clamp Techniques | 1 | 2025 | 300 | 0.060 |
Why?
|
| Heme Oxygenase-1 | 1 | 2024 | 32 | 0.060 |
Why?
|
| Cell Line | 2 | 2024 | 2864 | 0.050 |
Why?
|
| Diet, High-Fat | 1 | 2025 | 241 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2025 | 246 | 0.050 |
Why?
|
| Action Potentials | 1 | 2025 | 524 | 0.050 |
Why?
|
| Cell Survival | 1 | 2024 | 890 | 0.050 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2021 | 33 | 0.050 |
Why?
|
| Methylation | 1 | 2021 | 232 | 0.040 |
Why?
|
| Animals | 4 | 2025 | 36557 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2025 | 897 | 0.040 |
Why?
|
| Dihydrotestosterone | 1 | 2020 | 74 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2025 | 700 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2021 | 322 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 2539 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2020 | 402 | 0.040 |
Why?
|
| Environmental Exposure | 1 | 2020 | 246 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 400 | 0.030 |
Why?
|
| Rats | 1 | 2024 | 3890 | 0.030 |
Why?
|
| Apoptosis | 1 | 2024 | 1946 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2020 | 645 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2025 | 4016 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2016 | 2137 | 0.030 |
Why?
|
| Pyridones | 1 | 2016 | 129 | 0.030 |
Why?
|
| Male | 4 | 2025 | 66127 | 0.030 |
Why?
|
| Neurons | 1 | 2025 | 2050 | 0.030 |
Why?
|
| Phenotype | 1 | 2024 | 4598 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 4808 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 720 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2016 | 418 | 0.030 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2012 | 5 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 611 | 0.020 |
Why?
|
| Nucleotide Motifs | 1 | 2012 | 48 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 1107 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 2669 | 0.020 |
Why?
|
| Response Elements | 1 | 2012 | 107 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 2178 | 0.020 |
Why?
|
| Automation, Laboratory | 1 | 2011 | 15 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1740 | 0.020 |
Why?
|
| Estrogens | 1 | 2012 | 525 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 440 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2011 | 294 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 1433 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2011 | 970 | 0.020 |
Why?
|
| Mutation | 1 | 2020 | 6338 | 0.020 |
Why?
|
| Genome, Human | 1 | 2012 | 1351 | 0.010 |
Why?
|
| United States | 1 | 2020 | 11763 | 0.010 |
Why?
|
| Female | 1 | 2016 | 71928 | 0.000 |
Why?
|